Skip to content
mp.weixin.qq.com· 医药云端工作室·· 5 hours agoPickScore63

NMPA Approves TCM 1.1-Class Zihua Wenfei Zhisou Granule and Three Classic Formula Granules Same Day

3款经典名方+1款1.1类中药新药,同日获批

In brief

China's NMPA approved four granule formulations on October 15, 2026: Zihua Wenfei Zhisou Granule, a Class 1.1 TCM innovative drug, plus three Class 3.1 classic-formula TCM products, Wenjing Tang Granule (Shandong Runzhong Pharmaceutical), Shaoyao Gancao Tang Granule and Yiguan Jian Granule, covering respiratory, gynecological, pain and digestive indications. Zihua Wenfei Zhisou Granule will enter the 2026 national reimbursement talks via the off-catalogue pre-application route.

Why it matters

Four TCM approvals in one day span the two main tracks of China's TCM innovation, including an exclusive Class 1.1 new drug.

Source: mp.weixin.qq.com · mp.weixin.qq.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org